HOME
PRODUCTS
SERVICES
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Mobile
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Anna Sowa-Staszczak Selected Research
Anna Sowa-Staszczak Research Topics
Disease
7
Neoplasms (Cancer)
01/2013 - 01/2009
4
Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2013 - 01/2012
3
Lymphoma (Lymphomas)
01/2008 - 01/2007
2
Insulinoma
04/2013 - 01/2012
2
Hypothyroidism
01/2013 - 01/2012
2
Atherosclerotic Plaque (Atheroma)
04/2012 - 09/2009
2
Chronic Kidney Failure (Chronic Renal Failure)
04/2012 - 09/2009
2
Thyroid Neoplasms (Thyroid Cancer)
01/2012 - 12/2011
2
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2007 - 01/2007
2
Necrosis
01/2004 - 01/2003
2
Poisoning
01/2004 - 01/2003
1
Vitamin D Deficiency
01/2013
1
Prostatic Neoplasms (Prostate Cancer)
01/2013
1
Thyroiditis
01/2013
1
Neoplasm Metastasis (Metastasis)
07/2012
1
Renal Cell Carcinoma (Grawitz Tumor)
01/2012
1
Hyperinsulinism (Hyperinsulinemia)
01/2012
1
Carcinoma (Carcinomatosis)
01/2012
1
Nesidioblastosis (Nesidioblastosis of Pancreas)
01/2012
1
Hyperplasia
01/2012
1
Hypoglycemia (Reactive Hypoglycemia)
01/2012
1
Thyroid Diseases (Thyroid Disease)
12/2011
1
Atherosclerosis
09/2009
1
Inflammation
09/2009
1
Pheochromocytoma
01/2008
1
Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2008
1
Lymphatic Diseases (Lymphadenopathy)
01/2007
1
Carcinoid Tumor (Carcinoid)
01/2005
1
Coronary Occlusion
01/2004
1
Proteinuria
01/2003
1
Pituitary Neoplasms (Pituitary Adenoma)
01/2003
1
Hypoproteinemia
01/2003
1
Hyperthyroidism
01/2003
1
Hypoalbuminemia
01/2003
1
Protein-Losing Enteropathies (Protein-Losing Enteropathy)
01/2003
1
Heart Injuries
01/2003
1
Adenoma (Adenomas)
01/2003
Drug/Important Bio-Agent (IBA)
5
Somatostatin (Somatotropin Release-Inhibiting Factor)
IBA
01/2013 - 01/2008
4
Somatostatin Receptors (Somatostatin Receptor)
IBA
01/2013 - 01/2008
3
EDDA (NiEDDA)
IBA
04/2013 - 01/2005
2
papillary Thyroid cancer
IBA
01/2013 - 12/2011
2
hydroxide ion
IBA
01/2013 - 01/2013
2
Interleukin-2 (IL2)
IBA
04/2012 - 09/2009
2
Biological Markers (Surrogate Marker)
IBA
09/2009 - 01/2003
2
Immunoconjugates (Immunoconjugate)
IBA
01/2007 - 01/2007
2
Yttrium
IBA
01/2007 - 01/2007
2
Carbon Monoxide
IBA
01/2004 - 01/2003
2
Lactic Acid
FDA Link
Generic
01/2004 - 01/2003
1
exenatide (Byetta)
FDA Link
04/2013
1
glucagon-like peptide receptor (receptor, glucagon-like peptide)
IBA
04/2013
1
Glucagon-Like Peptide 1 (GLP 1)
IBA
04/2013
1
Thyroxine (Levothyroxine)
FDA Link
Generic
01/2013
1
Isotopes
IBA
01/2013
1
Cholecalciferol (Vitamin D3)
FDA Link
01/2013
1
Factor IX (PTC)
FDA Link
Generic
01/2013
1
Peptide Receptors (Peptide Receptor)
IBA
07/2012
1
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
01/2012
1
Glucose (Dextrose)
FDA Link
Generic
01/2012
1
Insulin (Novolin)
FDA Link
01/2012
1
sorafenib (BAY 43-9006)
FDA Link
01/2012
1
Iodine
IBA
12/2011
1
follicular Thyroid cancer
IBA
12/2011
1
Ligands
IBA
01/2008
1
Monoclonal Antibodies
IBA
01/2007
1
rituximab (Mabthera)
FDA Link
01/2007
1
Thyrotropin (Thyroid-Stimulating Hormone)
FDA Link
01/2003
1
Serum Albumin
IBA
01/2003
1
Hormones
IBA
01/2003
1
Thyroid Hormones
IBA
01/2003
1
Immunoglobulin G (IgG)
IBA
01/2003
1
Creatine Kinase (Creatine Phosphokinase)
IBA
01/2003
Therapy/Procedure
2
Neoadjuvant Therapy
01/2012 - 01/2012
2
Radioimmunotherapy
01/2007 - 01/2007
1
Tracheotomy
01/2012
1
Laparotomy
01/2012
1
Peritoneal Dialysis
09/2009
1
Aftercare (After-Treatment)
01/2008
1
Radiotherapy
01/2007